SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Debt Securities, Trading, Unrealized Gain
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Debt Securities, Trading, Unrealized Gain of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesTradingUnrealizedGain · last filed 2025-02-26
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. debt securities, trading, unrealized gain for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. debt securities, trading, unrealized gain for fiscal 2023 was $100.00K.
| Period end | Debt Securities, Trading, Unrealized Gain 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2023-12-31 | $100.00K 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |